10,000+ stock pitches from top investors available on joinyellowbrick.com
RA CAPITAL MANAGEMENT, L.P. 13F Holdings
Holdings from the most recent 13F from RA CAPITAL MANAGEMENT, L.P.
Filed: 2021-11-15 (Q3 2021) | Holdings: 95 | Value: $7.2B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| ASND - ASCENDIS PHARMA A/S | Add 9% ($92.7M) | 16.32% | $1.2B | +16.40% | -22.83% | -24.71% | |
| NVAX - NOVAVAX INC | Reduce 18% $(95.8M) | 6.03% | $434.9M | -95.83% | -48.39% | -87.20% | |
| ELYM - ELIEM THERAPEUTICS INC | New Purchase | 3.28% | $236.5M | -93.11% | -47.06% | -83.89% | |
| IVVD - ADAGIO THERAPEUTICS INC | New Purchase | 3.13% | $225.6M | -95.48% | -66.34% | -83.73% | |
| FMTX - FORMA THERAPEUTICS HLDGS INC | 2.90% | $209.0M | -37.86% | ||||
| CTKB - CYTEK BIOSCIENCES INC | New Purchase | 2.85% | $205.7M | -85.65% | -35.61% | -37.37% | |
| AVIR - ATEA PHARMACEUTICALS INC | Add 1% ($2.1M) | 2.64% | $190.3M | -72.02% | -44.21% | -57.63% | |
| JANX - JANUX THERAPEUTICS INC | 2.60% | $187.5M | +17.90% | -18.67% | -25.24% | ||
| VOR - VOR BIOPHARMA INC | 2.42% | $174.4M | -98.75% | -47.65% | -74.83% | ||
| AVTE - AEROVATE THERAPEUTICS INC | 2.40% | $173.4M | -47.82% | +13.12% | |||
| ICVX - ICOSAVAX INC | New Purchase | 2.37% | $171.0M | -28.07% | -90.24% | ||
| DICE - DICE THERAPEUTICS INC | New Purchase | 2.36% | $170.6M | -47.62% | +1.74% | ||
| CNTB - CONNECT BIOPHARMA HLDGS LTD | 2.35% | $169.4M | -94.16% | -66.29% | -94.38% | ||
| NKTX - NKARTA INC | 2.16% | $155.9M | -90.13% | -43.83% | -47.06% | ||
| ABOS - ACUMEN PHARMACEUTICALS INC | New Purchase | 2.01% | $145.2M | -91.00% | -50.97% | -48.28% | |
| TGTX - TG THERAPEUTICS INC | Add 23% ($25.1M) | 1.89% | $136.4M | +47.19% | -57.94% | -68.31% | |
| TVTX - TRAVERE THERAPEUTICS INC | 1.89% | $136.2M | -49.97% | -3.13% | -28.08% | ||
| TYRA - TYRA BIOSCIENCES INC | New Purchase | 1.76% | $127.3M | -63.69% | -54.69% | -72.97% | |
| MGNX - MACROGENICS INC | 1.72% | $124.5M | -92.54% | -42.39% | -65.33% | ||
| ITOS - ITEOS THERAPEUTICS INC | 1.65% | $119.3M | -66.63% | +14.52% | -29.20% | ||
| DAWN - DAY ONE BIOPHARMACEUTICALS I | 1.63% | $117.8M | -67.28% | -35.38% | -0.14% | ||
| IMGN - IMMUNOGEN INC | 1.45% | $104.4M | -1.41% | -8.79% | |||
| PHAT - PHATHOM PHARMACEUTICALS INC | 1.39% | $100.0M | -78.04% | -10.44% | -52.95% | ||
| PCVX - VAXCYTE INC | Add 1% ($787.9K) | 1.37% | $98.9M | +33.49% | -21.52% | +66.28% | |
| ETNB - 89BIO INC | 1.35% | $97.3M | -42.92% | -71.23% | -47.28% | ||
| TIL - INSTIL BIO INC | 1.21% | $87.1M | -92.67% | -38.38% | -90.48% | ||
| CLDX - CELLDEX THERAPEUTICS INC NEW | New Purchase | 1.20% | $86.4M | -54.33% | -25.40% | -19.46% | |
| KNTE - KINNATE BIOPHARMA INC | 1.15% | $82.7M | -51.84% | -56.07% | |||
| HOWL - WEREWOLF THERAPEUTICS INC | 1.02% | $73.6M | -92.22% | -53.61% | -88.16% | ||
| TNYA - TENAYA THERAPEUTICS INC | New Purchase | 1.02% | $73.3M | -97.70% | -36.50% | -86.41% | |
| PNT - POINT BIOPHARMA GLOBAL | New Purchase | 0.94% | $68.1M | -22.84% | -32.36% | ||
| GHRS - GH RESEARCH PLC | Add 1% ($772.1K) | 0.92% | $66.5M | -43.07% | -14.40% | -51.29% | |
| RYTM - RHYTHM PHARMACEUTICALS INC | 0.88% | $63.6M | +411.44% | -48.76% | +97.91% | ||
| RCKT - ROCKET PHARMACEUTICALS INC COM | 0.87% | $63.0M | -89.25% | -21.82% | -24.46% | ||
| CCCC - C4 THERAPEUTICS INC | 0.85% | $61.5M | -96.48% | -44.23% | -76.52% | ||
| CNTA - CENTESSA PHARMACEUTICALS PLC | New Purchase | 0.83% | $59.7M | -1.98% | -18.51% | -71.57% | |
| OLMA - OLEMA PHARMACEUTICALS INC | 0.82% | $59.3M | -83.99% | -81.18% | -88.25% | ||
| CYT - CYTEIR THERAPEUTICS INC | Add 3% ($1.8M) | 0.81% | $58.8M | -58.74% | -89.96% | ||
| PMVP - PMV PHARMACEUTICALS INC | 0.71% | $51.0M | -96.09% | -30.50% | -57.61% | ||
| ZGNX - ZOGENIX INC | Reduce 37% $(29.6M) | 0.70% | $50.6M | +77.42% | |||
| DYN - DYNE THERAPEUTICS INC | 0.63% | $45.6M | -4.64% | -49.28% | -33.33% | ||
| GRPH - GRAPHITE BIO INC | 0.61% | $44.2M | |||||
| EWTX - EDGEWISE THERAPEUTICS INC | 0.60% | $43.4M | -24.43% | -32.74% | -49.11% | ||
| VERV - VERVE THERAPEUTICS INC | 0.57% | $41.4M | -87.44% | -33.76% | -45.65% | ||
| GERN - GERON CORP | 0.57% | $41.3M | +3.31% | -29.80% | +48.34% | ||
| ACHL - ACHILLES THERAPEUTICS PLC | 0.54% | $39.1M | -37.35% | -66.90% | |||
| RXST - RXSIGHT INC | New Purchase | 0.54% | $38.7M | +23.71% | +14.01% | +15.67% | |
| WVE - WAVE LIFE SCIENCES LTD | 0.53% | $38.1M | +47.70% | -36.54% | -27.13% | ||
| KALV - KALVISTA PHARMACEUTICALS INC | 0.47% | $33.7M | -20.37% | -8.14% | -69.24% | ||
| DSGN - DESIGN THERAPEUTICS INC | 0.45% | $32.1M | -79.96% | -24.50% | -33.67% | ||
| ARDX - ARDELYX INC | Reduce 100% | 0.00% | $0.00 | +406.25% | -34.08% | +53.57% | |
| AXSM - AXSOME THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | +156.72% | -17.38% | +34.47% | |
| CERE - CEREVEL THERAPEUTICS HLDNG INC | Reduce 100% | 0.00% | $0.00 | ||||
| CCXI - CHEMOCENTRYX INC | Reduce 100% | 0.00% | $0.00 | ||||
| CRIS - CURIS INC | Reduce 100% | 0.00% | $0.00 | ||||
| KALA - KALA PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| LEGN - LEGEND BIOTECH CORP | Reduce 100% | 0.00% | $0.00 | -19.93% | -20.82% | -1.69% | |
| ORTX - ORCHARD THERAPEUTICS PLC | Reduce 100% | 0.00% | $0.00 | -35.71% | -73.51% | ||
| STSA - SATSUMA PHARMACEUTICALS INC | Reduce 100% | 0.00% | $0.00 | ||||
| SPRY - SILVERBACK THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||
| SLDB - SOLID BIOSCIENCES INC | Reduce 100% | 0.00% | $0.00 | ||||
| TRIL - TRILLIUM THERAPEUTICS INC | Reduce 100% | 0.00% | $0.00 | ||||